Quickfire Q&A delivers in-person insights from congress, bringing expert perspectives on the studies and data shaping clinical practice.
In this episode, recorded at the American Society of Clinical Oncology (ASCO) Annual Meeting 2026, we speak to Elizabeth Mittendorf, ASCO President and Director of Breast Surgery at Dana-Farber Cancer Institute, Boston, Massachusetts, USA, about advances in cancer immunotherapy and her vision for the future of oncology care.
Key topics discussed include:
- Cancer immunotherapy: How early breast cancer vaccine research helped inform advances in immune-based treatments
- Intentional oncology teams: Why supporting every member of the care team can improve patient experiences and outcomes
- The future of cancer care: Expanding global collaboration, investing in early career investigators, and personalizing treatment to minimize toxicity
Read the latest issue of AMJ Oncology for more expert insights and highlights from ASCO 2026.
